~8 spots leftby Apr 2026

Pre-surgical Aerobic Exercise for Cancer

Recruiting in Palo Alto (17 mi)
+7 other locations
LW
Overseen byLee W. Jones, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase < 1
Waitlist Available
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to find the safest level of aerobic training for people about to undergo surgery for their cancer, and to learn what effects, if any, aerobic exercise has on these patients and the outcomes of their cancers. This part of the study (Phase 0) will evaluate the feasibility and quality of at-home exercise and assessment procedures and find out whether study participants are willing to practice continuous lifestyle monitoring using apps and electronic devices. Phase 1a will compare the effects and feasibility of six different doses of aerobic exercise and will continue evaluating the quality of at-home study procedures, which includes the use of continuous lifestyle monitoring through apps and electronic devices. In order to facilitate completion of the phase 1a component, we will backfill the 90, 225, and 300 mins/wk dosing cohorts with at least 4 patients in each dose cohort.

Research Team

LW

Lee W. Jones, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for adults over 18 with a BMI ≤ 40 who have been diagnosed with early-stage breast, endometrial, or prostate cancer and are scheduled for surgery. They should not be doing more than minimal structured exercise weekly and must be willing to follow study procedures including at-home exercise and lifestyle monitoring.

Inclusion Criteria

- If BMI >40, patients may be eligible, at the discretion of the PI
I have prostate cancer that has not been treated yet, but I am scheduled for surgery.
- Performing </= 30 minutes of structured moderate-intensity or strenuous-intensity exercise per week, as evaluation by self report. If > 30 minutes but less than 90 minutes, patients may be eligible, at the discretion of the PI.
See 15 more

Exclusion Criteria

I am a man taking hormone therapy for cancer.
Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation.
I am not part of any other clinical trials that could affect this study's results, except those approved by the study leader.
See 5 more

Treatment Details

Interventions

  • Treadmill Walking (Behavioural Intervention)
Trial OverviewThe study tests different levels of pre-surgical aerobic exercise (treadmill walking) on patients with solid tumors. It aims to determine the safest exercise dose and its effects on patient health and cancer outcomes using apps and devices for continuous monitoring.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Pilot "Proof-of-Concept"Experimental Treatment1 Intervention
Individualized, progressive aerobic training consisting of treadmill walking for a total of 150 mins/wk delivered over 5 sessions/wk following a linear (breast, prostate, and endometrial) or non-linear (lung) dosing schedule for a minimum of 2 weeks.
Group II: Phase 1a: Dose-Finding / EscalationExperimental Treatment1 Intervention
Individualized, progressive aerobic training consisting of treadmill walking ranging from a total of 90 mins/wk to 450 mins/wk delivered over 3 to 7 sessions/wk following a linear or non-linear dosing schedule for a minimum of 2 weeks. If a patient is temporarily unable to complete supervised sessions as a result of unforeseen circumstances, patients may be assigned low intensity unsupervised training sessions per EP/PI discretion.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+
Lisa M. DeAngelis profile image

Lisa M. DeAngelis

Memorial Sloan Kettering Cancer Center

Chief Medical Officer since 2021

MD from Columbia University

Selwyn M. Vickers profile image

Selwyn M. Vickers

Memorial Sloan Kettering Cancer Center

Chief Executive Officer since 2022

MD from Johns Hopkins University

Vanderbilt University

Collaborator

Trials
714
Recruited
6,143,000+
Robert L. Caldwell profile image

Robert L. Caldwell

Vanderbilt University

Chief Executive Officer since 2003

PhD in Pathology from Vanderbilt University

Rick Wright profile image

Rick Wright

Vanderbilt University

Chief Medical Officer since 2023

MD from Washington University School of Medicine in St. Louis